Project 4 will investigate integration of patient-specific data (acquired from anatomic and physiological imaging and clinical Studies before and during therapy) together with other data and models of tumor and normal tissue response into individualized adaptive plan optimization. Though delivering the dose distribution that was prescribed at the beginning of treatment has been the goal of modifications of standard radiation planning, it is likely that this goal is not the best overall objective for each patient, when one takes into account the additional clinical and other information which can become available during the course of therapy. That is, each patient, and their tumor, changes over the course of treatment. However, approaches to deal with these changes have been makeshift and focused, in isolation, on only one issue at a time. The sum of those single-step corrections is vety unlikely to achieve the overall best solution for the patient. Therefore, the overall goal of this project is to develop and study methods that will integrate important clinical, imaging, and biological data and changes into an overall planning strategy to optimize each patient's treatment course in order to truly individualize therapy. Thus, this project addresses needed research on utilizing imaging and clinical response factors for decision support, adaptive treatment strategies and plan optimization. In particular, Specific Aim 1 will be tasked with organizing the expanse of population and patient specific data that exists and applying that information to provide knowledge-based decision support to help facilitate the best adaptive course of patient treatment.
Specific Aim 2 will design and investigate the adaptive treatment strategies that will lead to the greatest therapeutic gain for individual patients. The goal of Specific Aim 3 is to provide the radiation therapy treatment plan or set of plans that epitomizes the recommended course of therapy for each patient. Adaptive clinical trial strategies for the treatment sites studied in Projects 1 and 2 will be formulated;and we will run simulations to test these strategies for a variety of scenarios. Uncertainty assessments determined in Project 3 will also be incorporated. As part of the adaptive strategies will depend on planning quality, optimization studies will continue towards improving the quality and ease of achieving the best plans that take advantage of improved knowledge with regard to individual patient responses.

Public Health Relevance

The outcome of this research will be to demonstrate that individualized (adaptive) treatments can be both effectively and efficiently managed through the use of knowledge-guided decision support tools. The proposed work in this project is expected to drive the field toward a new paradigm of individualized, response-driven, adaptive radiotherapy plan optimization.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA059827-16A1
Application #
8609643
Study Section
Special Emphasis Panel (ZCA1-RPRB-C (O1))
Project Start
1997-02-01
Project End
2019-04-30
Budget Start
2014-05-15
Budget End
2015-04-30
Support Year
16
Fiscal Year
2014
Total Cost
$411,639
Indirect Cost
$144,858
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Ohri, Nitin; Tomé, Wolfgang A; Méndez Romero, Alejandra et al. (2018) Local Control After Stereotactic Body Radiation Therapy for Liver Tumors. Int J Radiat Oncol Biol Phys :
Mendiratta-Lala, Mishal; Gu, Everett; Owen, Dawn et al. (2018) Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 102:1063-1069
Wang, Shulian; Campbell, Jeff; Stenmark, Matthew H et al. (2018) A model combining age, equivalent uniform dose and IL-8 may predict radiation esophagitis in patients with non-small cell lung cancer. Radiother Oncol 126:506-510
Sapir, Eli; Tao, Yebin; Schipper, Matthew J et al. (2018) Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 100:122-130
Hawkins, Peter G; Boonstra, Philip S; Hobson, Stephen T et al. (2018) Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels. Transl Oncol 11:102-108
Sun, Yilun; Hawkins, Peter G; Bi, Nan et al. (2018) Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 100:107-114
Kong, Feng-Ming Spring; Li, Ling; Wang, Weili et al. (2018) Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer. Radiother Oncol :
Shilkrut, Mark; Sapir, Eli; Hanasoge, Sheela et al. (2018) Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases. Am J Clin Oncol 41:326-331
Jackson, William C; Tao, Yebin; Mendiratta-Lala, Mishal et al. (2018) Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys 100:950-958
Miften, Moyed; Vinogradskiy, Yevgeniy; Moiseenko, Vitali et al. (2018) Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys :

Showing the most recent 10 out of 289 publications